Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Primary Peritoneal Cancer
Related studies linked through entity extraction aliases.
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
- Status
- COMPLETED
- Phase
- N/A
Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
- Status
- COMPLETED
- Phase
- PHASE1
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2